Edwin Maldonado, MD
Interventional Pain Medicine · Palm Beach Gardens, FLNPI 1184648362
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (57.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Spinal Simplicity, LLC accounts for 68.4% of it on its own, with 26 other manufacturers making up the rest. Reporting peaked in 2021 at $16,811 and has fallen 87.2% since, to $2,160 in 2025.
Across 308 payments — averaging $84.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Spinal Simplicity, LLC$18K
- Boston Scientific$2K
- Abbott$2K
- Vertos Medical, Inc.$1K
- Collegium Pharmaceutical, Inc.$681
- Forte Bio-pharma LLC$301
- plus $2K from 21 others
What the payments were for
- Travel & lodging$1,6496%
- Food & beverage$9,37736%
- Education$15,12958%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Spinal Simplicity, LLC | 68 | $17,885 |
| Boston Scientific | 33 | $2,213 |
| Abbott | 68 | $1,922 |
| Vertos Medical, Inc. | 17 | $1,421 |
| Collegium Pharmaceutical, Inc. | 41 | $681 |
| Forte Bio-pharma LLC | 17 | $301 |
| Valinor Pharma, LLC | 10 | $183 |
| Interventional Pain Technologies Inc. | 5 | $173 |
| Medtronic(2 entities) | 6 | $170 |
| Nalu Medical, Inc. | 1 | $153 |
| Si-bone, Inc. | 2 | $145 |
| Protega Pharmaceutials Inc | 5 | $121 |
| MML US, Inc. | 2 | $107 |
| Amgen | 7 | $95 |
| Globus Medical | 3 | $94 |
| Scilex Pharmaceuticals Inc. | 4 | $92 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $74 |
| Daiichi Sankyo Inc. | 3 | $56 |
| Nevro Corp. | 1 | $55 |
| Biotronik NRO, Inc. | 2 | $44 |
| Kowa Pharmaceuticals America, Inc. | 2 | $43 |
| Redhill Biopharma Inc. | 2 | $41 |
| Relievant Medsystems, Inc. | 1 | $25 |
| IBSA Pharma Inc. | 1 | $21 |
| Shockwave Medical, Inc | 1 | $15 |
| Sentynl Therapeutics, Inc. | 1 | $14 |
| Electronic Waveform Lab, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$26,154 in reported general payments places this provider in the 85th percentile of 278 interventional pain medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 147 | $157,484 |
| Xtampza ErOxycodone Myristate | 165 | $140,489 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 3,192 | $116,055 |
| MovantikNaloxegol Oxalate | 225 | $91,983 |
| Oxycodone Hcl | 1,710 | $39,459 |
| Morphine Sulfate ErMorphine Sulfate | 819 | $29,642 |
| Fentanyl | 195 | $29,267 |
| LinzessLinaclotide | 51 | $27,210 |
| Lidocaine | 290 | $24,130 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,029 | $23,379 |
| Diclofenac Sodium | 506 | $18,657 |
| Gabapentin | 1,414 | $14,495 |
| Tizanidine Hcl | 1,420 | $13,649 |
| Pregabalin | 573 | $12,742 |
| Morphine Sulfate | 157 | $6,502 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er | $681 | $140,489165 claims |
| Redhill Biopharma Inc.Movantik | $41 | $91,983225 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 278 interventional pain medicine providers in Florida.
Other interventional pain medicine in Palm Beach Gardens
- Louis RasoJupiter$1.3M
- Ajay AntonyGainesville$1.1M
- Michael EspositoVero Beach$777K
- Nomen AzeemRiverview$650K
- Stanley GolovacMerritt Island$367K
- Sunil PanchalLutz$363K
- Robert BallPort Charlotte$246K
- Justin MannJacksonville$243K
- Giuseppe PaeseBoca Raton$180K
- Miguel de la GarzaNew Port Richey$138K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.